Skip to main content

Advertisement

SpringerLink
Log in

Tissue-type plasminogen activator activity in morphologically normal tissues adjacent to gastrointestinal carcinomas is associated with the degree of tumor progression

  • Original Paper
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose: To investigate whether the level of plasminogen activator (PA) activity assayed in gastrointestinal carcinomas and the “morphologically normal tissues” adjacent to them is associated with the degree of tumor progression. Methods: Tumor and “normal tissues” were obtained from gastrointestinal surgical samples to assess urokinase-type (u-PA) and tissue-type plasminogen activator (t-PA) activities by radial caseinolytic assay and the expression of PA inhibitor-1 (PAI-1) by ELISA. We compared the PA system between the tumor and “normal tissues” and we investigated the existence of correlations between: (a) PA production in the tumor and “normal tissues”, (b) different components of the PA system, and (c) PA system and the degree of tumor progression. Results: (1) Total PA activity, u-PA activity and PAI-1 expression are significantly higher in tumor than in “normal tissues”, whereas t-PA activity does not differ between them. (2) Total PA activity mainly correlates with u-PA activity in tumor tissues and similarly with u-PA and t-PA activities in “normal tissues”. (3) There is a significant association between t-PA activity in tumor and “normal tissues” and the degree of tumor progression. Conclusions: “Morphologically normal tissues” adjacent to carcinomas present abnormal t-PA activity that is associated with the degree of tumor progression. Assaying of this activity could be useful as a predictive parameter.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Abe J, Urano T, Konno H, Erhan Y, Tanaka T, Nishino N, Takada A, Nakamura S (1999) Larger and more invasive colorectal carcinoma contains larger amounts of plasminogen activator inhibitor type1 and its relative ratio over urokinase receptor correlates well with tumor size. Cancer 86:2602–2611

    Article  PubMed  CAS  Google Scholar 

  • Andreasen PA, Engelund R, Petersen HH (2000) The plasminogen activation system in tumor growth, invasion and metastasis. CMLS Cell Mol Life Sci 57:25–40

    Article  CAS  Google Scholar 

  • Baker EA, Leaper DJ (2003) The plasminogen activator and matrix metalloproteinase systems in colorectal cancer: relationship to tumour pathology. Eur J Cancer 39:981–988

    Article  PubMed  CAS  Google Scholar 

  • Berger DH (2002) Plasmin/plasminogen system in colorectal cancer. World J Surg 26:767–771

    Article  PubMed  Google Scholar 

  • Berger DH, O’Mahony CA, Sheng H, Shao J, Albo D, DuBois RN, Beauchamp RD (2003) Intestinal transformation results in transforming growth factor-beta-dependent alteration in tumor cell-cell matrix interactions. Surgery 133:568–579

    Article  PubMed  Google Scholar 

  • Boccaccio C, Sabatino G, Medico E, Girolami F, Follenzi A, Reato G, Sottile A, Naldini L, Comoglio PM (2005) The MET oncogene drives a genetic programme linking cancer to haemostasis. Nature 434:396–400

    Article  PubMed  CAS  Google Scholar 

  • Cho JY, Chung HC, Noh SH, Roh JK, Min JS, Kim BS (1997) High level of Urokinase-type plasminogen activator is a new prognostic marker in patients with gastric carcinoma. Cancer 79:878–883

    Article  PubMed  CAS  Google Scholar 

  • Diaz VM, Hurtado M, Thomson TM, Reventos J, Paciucci R (2004) Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro. Gut 53:993–1000

    Article  PubMed  CAS  Google Scholar 

  • Duffy MJ, Duggan C (2004) The urokinase plasminogen activator system: a rich source of tumour markers for the individualised management of patients with cancer. Clin Biochem 37:541–548

    Article  PubMed  CAS  Google Scholar 

  • Evans DM, Sloan Stakleff KD (2004) Control of pulmonary metastases of rat mammary cancer by inhibition of uPA and COX-2, singly and in combination. Clin Exp Metastasis 21:339–346

    Article  PubMed  CAS  Google Scholar 

  • Frandsen TL, Holst-Hansen C, Nielsen BS, Christensen IJ, Nyengaard JR, Carmeliet P, Brunner N (2001) Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) in the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model. Cancer Res 61:532–537

    PubMed  CAS  Google Scholar 

  • Fox SB, Taylor M, Grondahl-Hansen J, Kakolyris S, Gatter KC, Harris AL (2001) Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer. J Pathol 195:236–243

    Article  PubMed  CAS  Google Scholar 

  • Fujii T, Obara T, Tanno S, Ura H, Kohgo Y (1999) Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 as a prognostic factor in human colorectal carcinomas. Hepatogastroenterology 46:2299–2308

    PubMed  CAS  Google Scholar 

  • Ganesh S, Sier CFM, Griffioen G, Vloedgraven HJM, de Boer A, Welvaart K, van de Velde CJH, van Krieken JHJM, Verheijen JH, Lamers CBHW, Verspaget HW (1994) Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer. Cancer Res 54:4065–4071

    PubMed  CAS  Google Scholar 

  • Ganesh S, Sier CFM, Heerding MM, van Krieken JH, Griffioen G, Weelvaart K, van de Velde CJ, Verheijen JH, Lamers CB, Verspaget HW (1996) Prognostic value of the plasminogen activation system in patients with gastric carcinoma. Cancer 77:1035–1043

    Article  PubMed  CAS  Google Scholar 

  • Ganesh S, Sier CFM, Heerding MM, van Krieken JH, Griffioen G, Welvaart K, van de Valde CJ, Verheijen JH, Lamers CB, Verspaget HW (1997) Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes’ stage B and C colorectal cancer. Br J Cancer 75:1793–1801

    PubMed  CAS  Google Scholar 

  • Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG (eds) (2002) American Joint Committee on Cancer Staging Manual, 6th edn. Berlin, Springer-Verlag

  • Grondahl-Hansen J, Ralfkiaer E, Kirkeby LT, Kristensen P, Lund LR, Dano K (1991) Localisation of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans. Am J Pathol 138:111–117

    PubMed  CAS  Google Scholar 

  • Heiss MM, Allgayer H, Gruetzner KU, Babic R, Jauch KW, Schildberg FW (1997) Clinical value of extended biologic staging by bone marrow micrometastases and tumor-associated proteases in gastric cancer. Ann Surg 226:736–744

    Article  PubMed  CAS  Google Scholar 

  • Herszenyi L, Plebani M, Carraro P, De Paoli M, Roveroni G, Cardin R, Foschia F, Tulassay Z, Naccarato R, Farinati F (2000) Proteases in gastrointestinal neoplastic diseases. Clin Chim Acta 291:171–187

    Article  PubMed  CAS  Google Scholar 

  • Illemann M, Hansen U, Nielsen HJ, Andreasen PA, Hoyer-Hansen G, Dano K, Nielsen BS (2004) Leading-edge myofibroblasts in human colon cancer express plasminogen activator inhibitor-1. Am J Clin Pathol 122:256–265

    Article  PubMed  CAS  Google Scholar 

  • Iwamoto J, Takahashi K, Mizokami Y, Otsubo T, Miura S, Narasaka T, Takeyama H, Omata T, Shimokoube K, Matsuoka T (2003) Expression of urokinase-type plasminogen activator and its receptor in gastric fibroblasts and effects of nonsteroidal antiinflammatory drugs and prostaglandin. Dig Dis Sci 48:2247–2256

    Article  PubMed  CAS  Google Scholar 

  • Kaneko T, Konno H, Baba M, Tanaka T, Nakamura S (2003) Urokinase-type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer. Cancer Sci 94:43–49

    Article  PubMed  CAS  Google Scholar 

  • Khan KMF, Howe LR, Falcone DJ (2004) Extracellular matrix-induced cyclooxygenase-2 regulates macrophage proteinase expression. J Biol Chem 279:22039–22046

    Article  PubMed  CAS  Google Scholar 

  • Kloblinski JE, Ahram M, Sloane BF (2000) Unraveling the role of proteases in cancer. Clin Chim Acta 291:113–135

    Article  Google Scholar 

  • Konno H, Baba M, Shoji T, Ohta M, Suzuki S, Nakamura S (2002) Cyclooxygenase-2 expression correlates with uPAR levels and is responsible for poor prognosis of colorectal cancer. Clin Exp Metastasis 19:527–534

    Article  PubMed  CAS  Google Scholar 

  • Li G, Yang T, Yan J (2002) Cyclooxygenase-2 increased the angiogenic and metastatic potential of tumor cells. Biochem Biophys Res Commun 299:886–890

    Article  PubMed  CAS  Google Scholar 

  • Lipkin M (1974) Phase 1 and phase 2 proliferative lesions of colonic epithelial cells in diseases leading to colonic cancer. Cancer 34:878–888

    Article  PubMed  CAS  Google Scholar 

  • Lowry OH, Rosebrough NJ, Farr AL, Randall PJ (1951) Protein measurement with Folin phenol reagent. J Biol Chem 193:265–275

    PubMed  CAS  Google Scholar 

  • Murata S, Eguchi Y, Terata N, Tani T, Kodama M (1998) Expression of HLA-DR and urokinase- type plasminogen activator in stage IV gastric cancer. Gastric Cancer 1:71–77

    Article  PubMed  Google Scholar 

  • Nekarda H, Schmitt M, Ulm K, Wenninger A, Vogesang H, Becker K, Roder JD, Fink U, Siewert JR (1994) Prognostic impact of urokinase plasminogen activator and its inhibitor PAI-1 in completed resected gastric cancer. Cancer Res 54:2900–2907

    PubMed  CAS  Google Scholar 

  • Nishikawa M, Stapleton PP, Freeman TA, Gaughan JP, Matsuda T, Daly JM (2004) NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model. J Am Coll Surg 199:428–435

    Article  PubMed  Google Scholar 

  • Noel A, Maillard C, Rocks N, Jost M, Chabottaux V, Sounni NE, Maquoi E, Cataldo D, Foidart JM (2004) Membrane associated proteases and their inhibitors in tumour angiogenesis. J Clin Pathol 57:577–584

    Article  PubMed  CAS  Google Scholar 

  • Okusa Y, Ichikura T, Mochizuki H (1999) Prognostic impact of stromal cell-derived urokinase-type plasminogen activator in gastric carcinoma. Cancer 85:1033–1037

    Article  PubMed  CAS  Google Scholar 

  • Papadopoulou S, Scorilas A, Yotis J, Arnogianaki N, Plataniotis G, Agnanti N, Talieri M (2002) Significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 (PAI-1) expression in human colorectal carcinomas. Tumour Biol 23:170–178

    Article  PubMed  CAS  Google Scholar 

  • Pelletier JP, Mineau F, Fernandes J, Kiansa K, Ranger P, Martel-Pelletier J (1997) Two NSAIDs, nimesulide and naproxen, can reduce the synthesis of urokinase and IL-6 while increasing PAI-1, in human OA synovial fibroblasts. Clin Exp Rheumatol 15:393–398

    PubMed  CAS  Google Scholar 

  • Pereyra-Alfonso S, Scicolone G, Fiszer de Plazas S, Pecci Saavedra J, Flores V (1995) Current Triton X-100 treatments do not allow a complete plasminogen activator extraction from developing nervous tissue. Neurochem Res 2:137–142

    Article  Google Scholar 

  • Raigoso P, Junco A, Andicoechea A, Gonzalez A, Garcia-Muniz JL, Allende MT, Garcia-Moran M, Vizoso F (2000) Tissue-type plaminogen activator (tPA) content in colorectal cancer and in surrounding mucosa: relationship with clinicopathologic parameters and prognostic significance. Int J Biol Markers 15:44–50

    PubMed  CAS  Google Scholar 

  • Sadowski T, Steinmeyer J (2002) Differential effects of nonsteroidal antiinflammatory drugs on the IL-1 altered expression of plasminogen activators and plasminogen activator inhibitor-1 by articular chondrocytes. Inflamm Res 51:427–433

    Article  PubMed  CAS  Google Scholar 

  • Sanz L, Vizoso F, Verez P, Allende MT, Corte MG, Abdel-Lah O, Martin A, Garcia-Muniz JL (2002) Prognostic significance of tissue-type plasminogen activator (tPA) content in gastric cancer and surrounding mucosa. Int J Biol Markers 17:169–176

    PubMed  CAS  Google Scholar 

  • Seiler N, Schneider Y, Gosse F, Schleiffer R, Raul F (2004) Polyploidisation of metastatic colon carcinoma cells by microtubule and tubuline interacting drugs: effects on proteolytic activity and invasiveness. Int J Oncol 25:1039–1048

    PubMed  CAS  Google Scholar 

  • Sier CFM, Verspaget HW, Griffioen G, Ganesh S, Vloedgraven HJM, Lamers CBHW (1993) Plasminogen activators in normal tissue and carcinomas of the human oesophagus and stomach. Gut 34:80–85

    Article  PubMed  CAS  Google Scholar 

  • Singh B, Berry JA, Shoher A, Ramakrishnan V, Lucci A (2005) COX-2 overexpression increases motility and invasion of breast cancer cells. Int J Oncol 26:1393–1399

    PubMed  CAS  Google Scholar 

  • Skelly MM, Troy A, Duffy MJ, Mulcahy HE, Duggan C, Connell TG, O’Donoghue DP, Sheahan K (1997) Urokinase-type plasminogen activator in colorectal cancer: relationship with clinicopathological features and patient outcome. Clin Cancer Res 3:1837–1840

    PubMed  CAS  Google Scholar 

  • Stephens RW, Nielsen HJ, Christensen IJ, Thorlacius-Ussing O, Sorensen S, Dano K, Brünner N (1999) Plasma urokinase receptor levels in patients with colorectal cancer: relationship to prognosis. J Natl Cancer Inst 91:869–874

    Article  PubMed  CAS  Google Scholar 

  • Vassalli JD, Belin D (1987) Amiloride selectively inhibits the urokinase-type plasminogen activator. FEBS Lett 214:187–191

    Article  PubMed  CAS  Google Scholar 

  • Verspaget HW, Sier CFM, Ganesh S, Griffioen G, Lamers CBHW (1995) Prognostic value of plasminogen activators and their inhibitors in colorectal cancer. Eur J Cancer 31A:1105–1109

    Article  PubMed  CAS  Google Scholar 

  • Viaje A, Slaga TJ, Wigler M, Weinstein IB (1977) Effects of antiinflammatory agents on mouse skin tumor promotion, epidermal DNA synthesis, phorbol ester-induced cellular proliferation and production of plasminogen activator. Cancer Res 37:1530–1536

    PubMed  CAS  Google Scholar 

  • Yang JL, Seetoo D, Wang Y, Ranson M, Berney CR, Ham JM, Russell PJ, Crowe PJ (2000) Urokinase type-plasminogen activator and its receptor in colorectal cancer: independent prognostic factors of metastasis and cancer-specific survival and potential therapeutic targets. Int J Cancer 89:431–439

    Article  PubMed  CAS  Google Scholar 

  • Zajicek G (1993) Cancer colon is a disease of the entire colonic mucosa. Cancer J 6:309

    Google Scholar 

Download references

Acknowledgements

We thank the Surgical Department of the “Diego Thompson” Hospital of San Martin for providing samples and Ms. Patricia López for the constructive critical review of the English language of the manuscript. This work was supported by grants from UBACYT and CONICET, Argentina.

Author information

Authors and Affiliations

  1. School of Medicine, Institute of Cell Biology and Neurosciences, “Prof E De Robertis”, University of Buenos Aires, Paraguay 2155, 1121, Buenos Aires, Argentina

    Gabriel Scicolone, Viviana Sanchez, Liliana Vauthay, Federico Fuentes, Alejandro Scicolone & Vladimir Flores

  2. Interdisciplinary Group in Theoretical Biology, Department of Biostructural Sciences, Favaloro University, 1078, Buenos Aires, Argentina

    Melina Rapacioli & Vladimir Flores

  3. Diego Thompson Hospital, San Martin, 1650, Buenos Aires, Prov. Argentina

    Alejandro Scicolone & Lorenzo Scicolone

Authors
  1. Gabriel Scicolone
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Viviana Sanchez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Liliana Vauthay
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Federico Fuentes
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alejandro Scicolone
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lorenzo Scicolone
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Melina Rapacioli
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Vladimir Flores
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gabriel Scicolone.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Scicolone, G., Sanchez, V., Vauthay, L. et al. Tissue-type plasminogen activator activity in morphologically normal tissues adjacent to gastrointestinal carcinomas is associated with the degree of tumor progression. J Cancer Res Clin Oncol 132, 309–319 (2006). https://doi.org/10.1007/s00432-005-0066-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-005-0066-4

Keywords

Search

Navigation